Venous thromboembolism (VTE) is a common complication of cancer and chemotherapy.
We evaluated the baseline clinical characteristics, thromboprophylaxis patterns, frequency …

In a recent issue of Cancer, Khorana et al. 1 concluded that venous thromboembolic events
(VTEs) are an increasingly frequent complication of hospitalization in cancer patients. We …

This is a literature review of the frequency of venous thromboembolism in hospitalized
patients with cancer and of the available evidence supporting the use of …

Background: Venous thromboembolism (VTE) prophylaxis remains underutilized,
particularly in cancer patients. We explored clinical predictors of prophylaxis in hospitalized …

Background Cancer patients hospitalized for an acute medical illness are considered to be
at high risk of venous thromboembolism (VTE). Information on bleeding and symptomatic …

BACKGROUND. Venous thromboembolism (VTE) contributes to morbidity and mortality in
cancer patients and is a frequent complication of anticancer therapy. In the current study, the …

Cancer patients are at higher risk for venous thromboembolism (VTE). Anticoagulants, when
used for prophylaxis, had successfully reduced the incidence of VTE in high risk patients …

Venous thromboembolism (VTE) is a significant cause of morbidity and mortality in patients
with cancer. The risk of VTE varies over the natural history of cancer, with the highest risk …

Cancer and its treatment are recognized risk factors for VTE. Compliance rate with published
VTE prophylaxis guidelines is low. Decision on when to offer prophylaxis for hospitalized …

BACKGROUND: Recent studies suggest that thromboprophylaxis is beneficial in preventing
venous thromboembolism (VTE) in cancer outpatients, but this is not widely adopted …